BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 26528715)

  • 1. MARCKS Signaling Differentially Regulates Vascular Smooth Muscle and Endothelial Cell Proliferation through a KIS-, p27kip1- Dependent Mechanism.
    Yu D; Makkar G; Dong T; Strickland DK; Sarkar R; Monahan TS
    PLoS One; 2015; 10(11):e0141397. PubMed ID: 26528715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The myristoylated alanine-rich C kinase substrate differentially regulates kinase interacting with stathmin in vascular smooth muscle and endothelial cells and potentiates intimal hyperplasia formation.
    Yu D; Gernapudi R; Drucker C; Sarkar R; Ucuzian A; Monahan TS
    J Vasc Surg; 2019 Dec; 70(6):2021-2031.e1. PubMed ID: 30929966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. KIS protects against adverse vascular remodeling by opposing stathmin-mediated VSMC migration in mice.
    Langenickel TH; Olive M; Boehm M; San H; Crook MF; Nabel EG
    J Clin Invest; 2008 Dec; 118(12):3848-59. PubMed ID: 19033656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myristoylated Alanine-Rich Protein Kinase Substrate (MARCKS) Regulates Small GTPase Rac1 and Cdc42 Activity and Is a Critical Mediator of Vascular Smooth Muscle Cell Migration in Intimal Hyperplasia Formation.
    Yu D; Makkar G; Strickland DK; Blanpied TA; Stumpo DJ; Blackshear PJ; Sarkar R; Monahan TS
    J Am Heart Assoc; 2015 Oct; 4(10):e002255. PubMed ID: 26450120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MARCKS silencing differentially affects human vascular smooth muscle and endothelial cell phenotypes to inhibit neointimal hyperplasia in saphenous vein.
    Monahan TS; Andersen ND; Martin MC; Malek JY; Shrikhande GV; Pradhan L; Ferran C; LoGerfo FW
    FASEB J; 2009 Feb; 23(2):557-64. PubMed ID: 18940893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liver X receptor agonists suppress vascular smooth muscle cell proliferation and inhibit neointima formation in balloon-injured rat carotid arteries.
    Blaschke F; Leppanen O; Takata Y; Caglayan E; Liu J; Fishbein MC; Kappert K; Nakayama KI; Collins AR; Fleck E; Hsueh WA; Law RE; Bruemmer D
    Circ Res; 2004 Dec; 95(12):e110-23. PubMed ID: 15539633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. c-myc and skp2 coordinate p27 degradation, vascular smooth muscle proliferation, and neointima formation induced by the parathyroid hormone-related protein.
    Sicari BM; Troxell R; Salim F; Tanwir M; Takane KK; Fiaschi-Taesch N
    Endocrinology; 2012 Feb; 153(2):861-72. PubMed ID: 22210745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered S-phase kinase-associated protein-2 levels are a major mediator of cyclic nucleotide-induced inhibition of vascular smooth muscle cell proliferation.
    Wu YJ; Bond M; Sala-Newby GB; Newby AC
    Circ Res; 2006 May; 98(9):1141-50. PubMed ID: 16574903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced expression of glucose transporter-1 in vascular smooth muscle cells via the Akt/tuberous sclerosis complex subunit 2 (TSC2)/mammalian target of rapamycin (mTOR)/ribosomal S6 protein kinase (S6K) pathway in experimental renal failure.
    Lin CY; Hsu SC; Lee HS; Lin SH; Tsai CS; Huang SM; Shih CC; Hsu YJ
    J Vasc Surg; 2013 Feb; 57(2):475-85. PubMed ID: 23265586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A receptor-specific function for Notch2 in mediating vascular smooth muscle cell growth arrest through cyclin-dependent kinase inhibitor 1B.
    Boucher JM; Harrington A; Rostama B; Lindner V; Liaw L
    Circ Res; 2013 Sep; 113(8):975-85. PubMed ID: 23965337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of Spry1 attenuates vascular smooth muscle proliferation by impairing mitogen-mediated changes in cell cycle regulatory circuits.
    Yang X; Gong Y; He Q; Licht JD; Liaw L; Friesel RE
    J Cell Biochem; 2018 Apr; 119(4):3267-3279. PubMed ID: 29105817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. STAT1 requirement for PKR-induced cell cycle arrest in vascular smooth muscle cells in response to heparin.
    Handy I; Patel RC
    Gene; 2013 Jul; 524(1):15-21. PubMed ID: 23597922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ras/ERK1 pathway regulation of p27KIP1-mediated G1-phase cell-cycle arrest in cordycepin-induced inhibition of the proliferation of vascular smooth muscle cells.
    Jung SM; Park SS; Kim WJ; Moon SK
    Eur J Pharmacol; 2012 Apr; 681(1-3):15-22. PubMed ID: 22366198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biphasic effect of p21Cip1 on smooth muscle cell proliferation: role of PI 3-kinase and Skp2-mediated degradation.
    Bond M; Sala-Newby GB; Wu YJ; Newby AC
    Cardiovasc Res; 2006 Jan; 69(1):198-206. PubMed ID: 16212951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GA-binding protein regulates KIS gene expression, cell migration, and cell cycle progression.
    Crook MF; Olive M; Xue HH; Langenickel TH; Boehm M; Leonard WJ; Nabel EG
    FASEB J; 2008 Jan; 22(1):225-35. PubMed ID: 17726090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutant parathyroid hormone-related protein, devoid of the nuclear localization signal, markedly inhibits arterial smooth muscle cell cycle and neointima formation by coordinate up-regulation of p15Ink4b and p27kip1.
    Fiaschi-Taesch N; Sicari B; Ubriani K; Cozar-Castellano I; Takane KK; Stewart AF
    Endocrinology; 2009 Mar; 150(3):1429-39. PubMed ID: 18845646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of canonical insulin signaling accelerates vascular smooth muscle cell proliferation and migration through changes in p27Kip1 regulation.
    Lightell DJ; Moss SC; Woods TC
    Endocrinology; 2011 Feb; 152(2):651-8. PubMed ID: 21190963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FAK in the nucleus prevents VSMC proliferation by promoting p27 and p21 expression via Skp2 degradation.
    Jeong K; Murphy JM; Ahn EE; Lim SS
    Cardiovasc Res; 2022 Mar; 118(4):1150-1163. PubMed ID: 33839758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcriptional regulation of S phase kinase-associated protein 2 by NR4A orphan nuclear receptor NOR1 in vascular smooth muscle cells.
    Gizard F; Zhao Y; Findeisen HM; Qing H; Cohn D; Heywood EB; Jones KL; Nomiyama T; Bruemmer D
    J Biol Chem; 2011 Oct; 286(41):35485-35493. PubMed ID: 21868379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sesamin Inhibits PDGF-Mediated Proliferation of Vascular Smooth Muscle Cells by Upregulating p21 and p27.
    Han JH; Lee SG; Jung SH; Lee JJ; Park HS; Kim YH; Myung CS
    J Agric Food Chem; 2015 Aug; 63(33):7317-25. PubMed ID: 26244686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.